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Introduction {#sec1}
============

NMDA-type glutamate receptors (NMDARs) are key mediators of excitatory synaptic transmission in the brain ([@bib66]) contributing to synaptic plasticity and relevant for many forms of learning and memory ([@bib47], [@bib39], [@bib32]). However, the precise molecular mechanism by which postsynaptic NMDARs are retained at the synapse to allow for activity-dependent plasticity and expression of cognitive functions is still mostly unexplored.

The functional and pharmacological properties, the interacting proteins, and the subcellular localization of NMDARs strictly depend on their subunit composition, namely, the combination of the obligatory subunit GluN1 with the regulatory subunits GluN2 (A--D) and GluN3 ([@bib51]). NMDAR subunit composition not only changes during neuronal development ([@bib4]) but at mature synapses can be modulated by synaptic activity and sensory experiences ([@bib54], [@bib55], [@bib56], [@bib59], [@bib69]) and can profoundly modify neuronal circuits and behavior. Recently, the unbalance in NMDAR subunit composition was recognized as a pivotal feature of several common neurological disorders ([@bib58], [@bib33], [@bib61], [@bib20], [@bib45]).

GluN2A-containing NMDARs are rather stable at synapses, and several mechanisms have been called upon to regulate their synaptic retention. The C-terminal domain (CTD) of GluN2A enables interaction with the PDZ domain of scaffolding proteins, anchoring the receptor at the postsynaptic membrane as well as expressing correct downstream events ([@bib26], [@bib60]; [@bib38], [@bib63]). Interestingly, mice lacking the CTD of GluN2A display impaired hippocampal long term potentiation (LTP) ([@bib62]). Our group has previously reported Rabphilin3A (Rph3A) as a novel GluN2A synaptic partner needed to stabilize GluN2A/PSD-95 complex at the postsynaptic density (PSD). Disruption of the Rph3A/GluN2A/PSD-95 complex reduced GluN2A synaptic retention associated with increased GluN2A-containing NMDARs endocytosis ([@bib63]). Notably, this event is also associated with reduced dendritic spine density both *in vitro* and *in vivo* ([@bib63]).

Many studies assigned specific roles for synaptic GluN2A-containing NMDARs in the induction of LTP and Long-Term Depression (LTD) ([@bib35], [@bib17], [@bib29]). Deletion of GluN2A leads to reduced hippocampal LTP and impaired spatial learning ([@bib57], [@bib31], [@bib30]). The use of GluN2A-specific antagonists prevented LTP but not LTD ([@bib35]). Similarly, selective inhibition of GluN2A-containing receptors with low Zn^2+^ concentrations impaired LTP but not LTD ([@bib52]). Finally, different studies demonstrated an increase in GluN2A-containing NMDARs at the PSD following LTP induction ([@bib3], [@bib4], [@bib53], [@bib1]), suggesting that NMDAR trafficking at synapses could play a relevant role in these events. However, many open questions remain about (1) the role of the complex of proteins responsible for synaptic retention of GluN2A-containing NMDARs in synaptic plasticity and (2) the link between GluN2A-containing NMDARs and cognitive behavior. Starting from these questions here we analyzed the role of Rph3A and Rph3A/GluN2A complex in the functional and morphological modifications of excitatory synapses following induction of LTP as well as in hippocampal NMDAR-dependent behaviors such as spatial learning.

Results {#sec2}
=======

Rph3A-Positive Dendritic Spines Are Characterized by an Increased Spine Head Area and PSD Size {#sec2.1}
----------------------------------------------------------------------------------------------

Rph3A is a known vesicle-associated presynaptic protein ([@bib34], [@bib7]) also highly enriched in dendritic spines at the lateral domain of the PSD ([@bib63]). Pre-embedding immunohistochemistry for Rph3A in rat *stratum radiatum* of the CA1 region of hippocampus revealed that 42.428 ± 2.301% of presynaptic terminals (n = 3632) and 48.275 ± 2.331% of dendritic spines (n = 3632) display Rph3A labeling ([Figures 1](#fig1){ref-type="fig"}A and 1B), thus indicating a similar enrichment of the protein at pre- and postsynaptic sites. We analyzed possible morphological differences between Rph3A positive (Rph3A+) and negative (Rph3A−) dendritic spines. Rph3A+ spines exhibit a highly significant increased spine head area (\*\*\*p \< 0.001; [Figures 1](#fig1){ref-type="fig"}C and 1D and [Table 1](#tbl1){ref-type="table"}) and PSD length (\*\*\*p \< 0.001; [Figures 1](#fig1){ref-type="fig"}E and 1F and [Table 1](#tbl1){ref-type="table"}) and also an augmented PSD thickness (\*p \< 0.05; [Figures 1](#fig1){ref-type="fig"}G and 1H and [Table 1](#tbl1){ref-type="table"}) compared to Rph3A− ones, thus defining a selective accumulation of the protein in more "mature" synapses.Figure 1Morphological Analysis of Rph3A-Positive and Rph3A-Negative Dendritic Spines(A and B) Representative electron micrographs of *stratum radiatum* CA1 region of Rph3A negative (A, left image; Rph3A−) and positive (B, right image; Rph3A+) spinous synapses, respectively. Scale bar, 125 nm.(C and D) Shifted distribution of spine head area toward bigger values in Rph3A+ spines (blue; n = 689/1,500, 3 rats) compared with Rph3A− spines (red; n = 811/1,500, 3 rats; p \< 0.001, Mann-Whitney Rank Sum Test).(E and F) Shifted distribution of PSD length toward bigger values in Rph3A+ spines (blue; n = 689/1,500, 3 rats) compared with Rph3A− spines (red; n = 811/1,500, 3 rats; p \< 0.001, Mann-Whitney Rank Sum Test).(G and H) Shifted distribution of PSD thickness toward bigger values in Rph3A+ spines (blue; n = 689/1,500, 3 rats) compared with Rph3A− spines (red; n = 811/1,500, 3 rats; p \< 0.05; Mann-Whitney Rank Sum Test).Table 1Morphological Analysis of Rph3a+ and Rph3A− Dendritic Spines (n = 3 Rats, 500 Spines/Rat)LabelingRph3A− Spines (n = 811/1,500)Rph3A+ Spines (n = 689/1,500)p Value (Rph3A+ versus Rph3A−)PSD length (nm)215 ± 2.38232 ± 2.87\<0.001PSD thickness (nm)54.5 ± 0.9656.7 ± 1.060.049Spine Head Area (nm^2^)99.9 ± 2.40143 ± 3.54\<0.001

Modulation of Rph3A/GluN2A Complex by Long-Term Potentiation {#sec2.2}
------------------------------------------------------------

It is well known that induction of LTP leads to an accumulation of GluN2A-containing NMDARs at the excitatory PSDs ([@bib3], [@bib23], [@bib4]). By using a previously validated protocol, here we treated rat primary hippocampal neurons with Forskolin/Rolipram/Picrotoxin cocktail to induce chemical LTP (cLTP; [@bib50], [@bib14]). Quantification of GluA1 Ser845 phosphorylation showed a significant increase of AMPA subunit phosphorylation levels after cLTP ([@bib15], [@bib49], [@bib27], [@bib40]; [Figure S1](#mmc1){ref-type="supplementary-material"}). We observed that cLTP was sufficient to increase the levels not only of GluN2A (\*\*p \< 0.01; [Figure 2](#fig2){ref-type="fig"}A) but also of Rph3A (\*p \< 0.05; [Figure 2](#fig2){ref-type="fig"}A) in postsynaptic membrane fractions (Triton insoluble fractions, TIF; [@bib19]) as measured 15 min after cLTP induction. Conversely, induction of cLTD ([@bib49], [@bib42]) did not induce any modification of GluN2A and Rph3A synaptic localization ([Figure S2](#mmc1){ref-type="supplementary-material"}).Figure 2Effect of Long-Term Potentiation on Rph3A/GluN2A Complex(A) Bar chart (left) and representative western blots (right) for GluN2A and Rph3A protein levels in TIF from hippocampal primary cultures after cLTP. cLTP induction was performed in artificial cerebrospinal fluid (ACSF) without MgCl~2~, plus 50 μM Forskolin, 0.1 μM Rolipram, and 100 μM Picrotoxin for 16 min. Control groups were kept in normal ACSF. After that, cells were incubated back in ACSF with MgCl~2~ for 15 min (n = 9, t test; \*p \< 0.05; \*\*p \< 0.01; data are expressed as mean ± SEM). Molecular weight markers are indicated on the right.(B) Dendritic spine positivity for Rph3A after cLTP in primary cultures (t test) and representative images (scale bar, 5 μm). \*\*p \< 0.01; data are expressed as mean ± SEM.(C) Morphological analysis of Rph3A-positive spines before and after cLTP treatment (t test). \*p \< 0.05; data are expressed as mean ± SEM.(D) Bar chart and representative images of PLA for Rph3A:PSD-95 (red bar) and Rph3A:GluN2A (green bar) in control cultures (CTR) and after cLTP (scale bar, 5 μm). Merge panels are shown in the right. \*p \< 0.05; \*\*p \< 0.01; data are expressed as mean ± SEM.(E) Bar graph and representative blots of GluN2A and Rph3A protein levels in TIF from hippocampal cultures after cLTP, with (cLTP + Anis) or without (cLTP) protein synthesis inhibitor Anisomycin (40 μM) (RM one-way ANOVA, n = 8); \*p \< 0.05; data are expressed as mean ± SEM. Molecular weight markers are indicated on the right.(F) Column graph and representative images of Puro-PLA analysis for Rph3A newly synthetized (Rph3A:puromycin) in dendritic and somatic compartments after cLTP in primary cultures (n = 39--43, scale bar, 10 μm).(G) Bar graph and representative images of GluN2A and Rph3A protein levels in hippocampal TIF from young mice housed in enriched environment (EE) compared with standard cages (CTRL). \*p \< 0.05; data are expressed as mean ± SEM. Molecular weight markers are indicated on the right.

The confocal microscopy analysis in GFP-transfected primary hippocampal neurons revealed that cLTP significantly increased the percentage of Rph3A+ spines compared with basal conditions ([Figure 2](#fig2){ref-type="fig"}B; \*\*p \< 0.01). A careful morphological analysis of dendritic spines showed that Rph3A was selectively enhanced in mushroom spines after cLTP ([Figure 2](#fig2){ref-type="fig"}C; \*p \< 0.05); no alteration of Rph3A localization was observed in stubby or thin spines ([Figure 2](#fig2){ref-type="fig"}C).

We performed Proximity Ligation Assay (PLA) to address whether Rph3A accumulation in spines leads also to its interaction with the GluN2A/PSD-95 complex ([@bib63]). Analysis of PLA clusters after cLTP in GFP-transfected neurons ([Figure 2](#fig2){ref-type="fig"}D) showed a statistically significant increase in Rph3A/PSD-95 (\*\*p \< 0.01) and GluN2A/Rph3A (\*p \< 0.05) interactions within dendritic spines.

The observed increase of Rph3A levels at postsynaptic sites after cLTP induction could be the result of a modulation of protein trafficking or novel protein synthesis. To clarify this point, we blocked protein synthesis through anisomycin (40 μM) during cLTP. Protein levels of GluN2A and Rph3A at synapses did not differ in the presence or absence of anisomycin ([Figure 2](#fig2){ref-type="fig"}E), thus suggesting that novel protein synthesis does not play a key role in these events. To confirm these results, we performed analysis of Rph3A local synthesis after cLTP through a PLA of puromycin and Rph3A (puro-PLA assay; see [Transparent Methods](#mmc1){ref-type="supplementary-material"}). This assay allows one to monitor the synthesis of novel Rph3A molecules in the different subcellular compartments ([@bib13]). As shown in [Figure 2](#fig2){ref-type="fig"}F, we did not observe any difference in the density of puromycin/Rph3A clusters between control and cLTP-treated neurons both in the soma and along dendrites. Overall, these *in vitro* data indicate that the cLTP-triggered accumulation of GluN2A/Rph3A/PSD-95 complexes at synapse cannot be ascribed to Rph3A *de novo* synthesis.

Housing animals in enriched environment conditions induces neuronal plasticity events and accumulation of GluN2A-containing NMDARs at synapses ([@bib54], [@bib55], [@bib56], [@bib59], [@bib69], [@bib22], [@bib65], [@bib6]). To evaluate whether Rph3A localizes at the postsynapse also after this *in vivo* plasticity, we purified the postsynaptic fraction from hippocampi of mice housed in enriched environment for 3 months or in standard cages. As previously reported, enriched environment promoted the increase of GluN2A-containing NMDARs at synapses ([Figure 2](#fig2){ref-type="fig"}G; \*p \< 0.05; [@bib54], [@bib55], [@bib56], [@bib59], [@bib69]). Similarly, the enriched environment induced also a significant increase of Rph3A levels in the postsynaptic fraction ([Figure 2](#fig2){ref-type="fig"}G; \*p \< 0.05).

Phospholipase C Activation Promotes Rph3A/GluN2A Interaction in the Postsynaptic Density {#sec2.3}
----------------------------------------------------------------------------------------

Different putative molecular mechanisms could be envisaged for the increased formation of the synaptic Rph3A/GluN2A complex induced by LTP. It is well known that LTP induces activation of tyrosine kinases (src/fyn) in the postsynaptic compartment leading to phosphorylation of NMDAR subunits ([@bib48], [@bib35]). In particular, GluN2A phosphorylation at Tyr1387, within the GluN2A domain involved in the interaction with Rph3A ([@bib63]), has been put forward for consideration ([@bib68]). However, as shown in [Figure S3](#mmc1){ref-type="supplementary-material"}A, cLTP did not change the phosphorylation of GluN2A Tyr1387 in cultured cells. Moreover, co-localization analysis in COS-7 cells transfected with Rph3A and GluN2Awt/GluN2A-Y1387E (mimicking phosphorylation) showed that GluN2A phosphorylation in this tyrosine residue did not alter the capability of the subunit to interact with Rph3A ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Overall, these experiments indicate that GluN2A phosphorylation in Tyr1387 does not represent the molecular event regulating GluN2A/Rph3A complex formation following LTP induction.

Rph3A, through both its C2A and C2B domains, binds inositol triphosphate (IP3) in a Ca^2+^-dependent manner ([@bib46], [@bib16]). Interestingly, IP3 and Ca^2+^ binding to the C2A domain are reciprocally modulated in a positive manner. In particular, Ca^2+^ induces a conformational rearrangement of a specific Rph3A loop (namely, CBL3), which is involved in IP3 binding ([@bib12], [@bib24]). Notably, IP3 and Ca^2+^ regulate also the formation of Rph3A complex with GluN2A ([@bib63]). Phospholipase C (PLC) cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into IP3 and diacylglycerol; afterward, IP3 releases Ca^2+^ from the ER, suggesting that activation could modulate the formation of Rph3A/GluN2A. PLCγ and PLCβ isoforms are both localized at the excitatory synapse and functionally associated to TrkB ([@bib21]) and group I metabotropic receptors (mGluR1/mGluR5; [@bib10], [@bib25]), respectively. Activation of group I of metabotropic glutamate receptors (mGluRs) through DHPG (50 μM) increased postsynaptic levels of both Rph3A ([Figure 3](#fig3){ref-type="fig"}A, \*p \< 0.05) and GluN2A ([Figure 3](#fig3){ref-type="fig"}A, \*p \< 0.05) but not GluN2B ([Figure 3](#fig3){ref-type="fig"}A). Under the same experimental conditions, DHPG augmented Rph3A-GluN2A interaction as evaluated by the co-immunoprecipitation assay ([Figure 3](#fig3){ref-type="fig"}B, \*\*\*p \< 0.001). Analysis of pERK phosphorylation was performed as a positive control of DHPG treatment ([@bib18]; [Figure S4](#mmc1){ref-type="supplementary-material"}, \*\*p \< 0.01).Figure 3mGluR/PLC Pathway Modulates Rph3A Synaptic Localization and Interaction with NMDAR(A) Column chart and representative blots in TIF from primary cultures treated with 3,5-R,S-DHPG (DHPG, 50 μM for 15 min). DHPG increased GluN2A and Rph3A significantly, whereas no difference could be inferred for GluN2B (t test, n = 5). \*p \< 0.05; data are expressed as mean ± SEM. Molecular weight markers are indicated on the right.(B) Graph and blots for co-immunoprecipitation of Rph3A and GluN2A from P2 fraction of primary cultures treated with DHPG. The analysis revealed increased binding of Rph3A with GluN2A (n = 4). \*\*\*p \< 0.001; data are expressed as mean ± SEM. Molecular weight markers are indicated on the right.(C) Bar graph and representative blots for Rph3A and tubulin in TIF from primary hippocampal neurons treated with BDNF (50 ng/mL, 3 h; n = 5; t test). \*p \< 0.05; data are expressed as mean ± SEM. Molecular weight markers are indicated on the right.

Finally, as further demonstration of the role of PLC in the modulation of Rph3A retention at the excitatory synapse, we showed that also the treatment of hippocampal primary cultures with the TrkB agonist Brain Derived Neurotrophic Factor (BDNF, 3 h, 50 ng/mL), leading to activation of the PLCγ pathway, increased Rph3A protein levels in the postsynaptic fraction ([Figure 3](#fig3){ref-type="fig"}C, \*p \< 0.05).

Modulation of Rph3A/GluN2A Complex Governs Plasticity at Molecular and Structural Level {#sec2.4}
---------------------------------------------------------------------------------------

To test the direct role of Rph3A in the membrane localization of GluN2A-containing NMDARs following induction of cLTP, we used a small hairpin RNA for Rph3A (tGFP-shRph3A) to downregulate Rph3A in the presence or absence of cLTP induction, and we evaluated the surface localization of the GluN2A subunit ([Figure 4](#fig4){ref-type="fig"}A). As expected ([@bib2]), induction of cLTP promoted an accumulation of GluN2A at the cell surface ([Figure 4](#fig4){ref-type="fig"}A, \*\*\*p \< 0.001). Notably, Rph3A silencing prevented GluN2A accumulation at the cell surface following induction of cLTP ([Figure 4](#fig4){ref-type="fig"}A, \*\*\*p \< 0.001 shSCR-cLTP versus shRph3A-cLTP), thus suggesting that formation of GluN2A/Rph3A complex is required for the stabilization of GluN2A at synapses following LTP.Figure 4Effect of Modulation of Rph3A/PLC Pathway on GluN2A Surface Staining, GluA1 Synaptic Localization and Spine Morphology(A) Bar graph and representative images of GluN2A surface expression before (CTRL) and after cLTP (cLTP) in tGFP-shScramble (shSCR) or tGFP-shRph3A transfected neurons. cLTP induction was performed in ACSF without MgCl~2~, plus 50 μM Forskolin, 0.1 μM Rolipram and 100 μM Picrotoxin for 16 min. Control groups were kept in normal ACSF. After that, cells were incubated back in ACSF with MgCl~2~ for 15 min (one-way ANOVA Tukey post hoc n = 41--46, scale bar, 4 μm); \*\*\*p \< 0.001.(B) Graph chart and representative images of GluA1 cluster width before and after cLTP in hippocampal neurons transfected with shSCR or shRph3A (one-way ANOVA Tukey post hoc, n = 9--11, scale bar, 4 μm); \*p \< 0.05, \*\*\*p \< 0.001.(C) Column graphs and representative images of shSCR or shRph3A transfected neurons before and after cLTP. cLTP induction was performed in ACSF without MgCl~2~, plus 50 μM Forskolin, 0.1 μM Rolipram, and 100 μM Picrotoxin for 16 min. Control groups were kept in normal ACSF. After that, cells were incubated back in ACSF with MgCl~2~ for 2 h (one-way ANOVA Tukey post hoc, n = 8, scale bar, 4 μm); \*\*p \< 0.01, \*p \< 0.05.(D) Inhibition of Phospholipase C with U73122 (1 μM) during cLTP on hippocampal primary cultures recapitulates control levels of Rph3A and GluN2A in TIF (one-way ANOVA Bonferroni post hoc, n = 5--7); \*p \< 0.05, \*\*\*p \< 0.001. Molecular weight markers are indicated on the right.(E) Bar chart and representative images of spine morphology analysis after cLTP induction in the presence (cLTP + U73122) or absence (cLTP) of U73122 (1 h after cLTP; one-way ANOVA Bonferroni post hoc, n = 25, scale bar, 4 μm); \*\*p \< 0.01. \*\*\*p \< 0.001.

It is well known that LTP also increases GluA1 clusters at synapses ([@bib41]). As shown in [Figures 4](#fig4){ref-type="fig"}B and 4C, induction of cLTP increased GluA1 cluster width ([Figure 4](#fig4){ref-type="fig"}B, \*\*\*p \< 0.001), paralleled by augmented spine density ([Figure 4](#fig4){ref-type="fig"}C, \*\*p \< 0.01) and spine head width ([Figure 4](#fig4){ref-type="fig"}C, \*p \< 0.05). Interestingly, Rph3A silencing completely prevented any modification of GluA1 cluster size ([Figure 4](#fig4){ref-type="fig"}B, \*p \< 0.05 shSCR-cLTP versus shRph3A-cLTP) and spine density ([Figure 4](#fig4){ref-type="fig"}C, \*p \< 0.05 shSCR-cLTP versus shRph3A-cLTP). Moreover, Rph3A silencing prevented the enlargement of spine head width induced by LTP ([Figure 4](#fig4){ref-type="fig"}C, p \> 0.05, shSCR-CTRL versus shRph3A-cLTP).

To evaluate the role of PLC in these events, we inhibited PLC activity through U73122 (1 μM) during cLTP. Co-incubation with PLC inhibitor recapitulated basal levels of both Rph3A (\*p \< 0.05, U73122 + cLTP versus cLTP) and GluN2A (\*p \< 0.05, U73122 + cLTP versus cLTP) in the postsynaptic fraction ([Figure 4](#fig4){ref-type="fig"}D). It is well known that LTP increases dendritic spine density in hippocampal neurons ([@bib9]). In addition, we previously reported that Rph3A silencing or disruption of its interaction with GluN2A is sufficient to reduce spine density in resting conditions ([@bib63]). Notably, we now observed that inhibition of PLC with U73122 during cLTP not only decreased synaptic localization of Rph3A/GluN2A complex ([Figure 4](#fig4){ref-type="fig"}D) but also completely blocked the increase in dendritic spine density produced by cLTP ([Figure 4](#fig4){ref-type="fig"}E; \*\*\*p \< 0.001 cLTP versus control; \*\*p \< 0.01 cLTP versus cLTP + U73122). Overall, these results suggest that PLC activation is required to modulate Rph3A/GluN2A retention at synapses needed for structural modifications following induction of LTP in primary hippocampal neurons.

Overall, the above-described results indicate that induction of cLTP in primary hippocampal neurons promotes synaptic enrichment of the Rph3A/GluN2A complex, demonstrating also a key role for Rph3A in LTP-dependent molecular and morphological modifications of dendritic spines, namely, LTP-dependent trafficking of AMPARs and formation of novel dendritic spines.

GluN2A/Rph3A Complex Is Necessary for LTP Induction and Spatial Learning {#sec2.5}
------------------------------------------------------------------------

We previously reported that perturbing GluN2A/Rph3A interaction *in vivo* with TAT-2A40 interfering peptide (containing the GluN2A1349-1389 domain involved in the interaction with Rph3A) decreases the amplitude of NMDAR-mediated currents and GluN2A levels at dendritic spines ([@bib63], [@bib64]). Here, we acutely treated adult mice with TAT-2A40 or its control TAT-scramble (TAT-SCR) peptide (3 nmol/g, i.p., single injection). One hour after the treatment, animals were sacrificed for *ex vivo* molecular and electrophysiological analyses. As previously reported ([@bib63], [@bib64]), treatment with TAT-2A40 leads to a specific reduction of GluN2A but not GluN2B subunits at synapses leading to an overall significant decrease of synaptic GluN2A/GluN2B ratio with no modification of GluN1 (see [Figure S5](#mmc1){ref-type="supplementary-material"}). LTP was induced by stimulation of Schaffer collaterals in CA1 *stratum radiatum* (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}). As expected, in hippocampal slices from animals treated with TAT-SCR peptide we observed the induction and the maintenance of the LTP ([Figures 5](#fig5){ref-type="fig"}A--5C). On the contrary, in hippocampal slices from animals treated with TAT-2A40 peptide, LTP induction was completely impaired ([Figures 5](#fig5){ref-type="fig"}A--5C; \*\*p \< 0.01).Figure 5*In Vivo* Effect of Rph3A/GluN2A Interfering Peptide on LTP Induction and Spatial Memory(A--C) Somatic whole-cell voltage-clamp recordings were made from CA1 pyramidal cells using 2--6 ΩM electrodes. The internal solution contained (in mM) 115 CsMeSO~4~, 20 CsCl~2~, 10 HEPES, 2.5 MgCl~2~, 4 NaATP, 0.4 NaGTP, 10 NaCreatine, and 0.6 EGTA (pH 7.2). Synaptic responses were collected with a Multiclamp 700B amplifier (Axon Instruments, Foster City, CA, USA), filtered at 2 kHz, digitized at 5 kHz, and analyzed online using Igor Pro Software (Wavemetrics, Lake Oswego, OR, USA). All data are expressed as mean ± SEM. Cells were held at −70 mV, and LTP protocol was induced by pairing the cell at 0 mV at a frequency of 2 Hz for 90 s. The amplitude of TAT-2A40 treated animals, as well as LTP kinetic, was completely impaired compared with TAT-SCR (AMPLITUDE, \*\*p \< 0.01, unpaired t test).(D and E) Mean discrimination index and mean exploration time evaluated in the Spatial Object Recognition test, 60 min after treatment; \*\*\*p \< 0.001 versus TAT-SCR Student\'s t test; §§§p \< 0.001 versus corresponding stationary object, TAT-SCR; two-way ANOVA followed by Bonferroni test.(F and G) Cumulative mean of horizontal (F) and vertical (G) counts evaluated for 10 min in an automated activity cage. N = 10 animals for each group.

Changes in NMDAR synaptic levels are triggered by synaptic plasticity and by spatial memory formation ([@bib2]). In particular, an increase in the synaptic GluN2A/GluN2B subunit ratio could act as a stabilizer of synaptic/circuital changes, hence leading to stabilization of memory consolidation, particularly spatial representations ([@bib2]). Starting from these considerations, we performed a spatial object recognition behavioral task to assess the effect of disrupting Rph3A/GluN2A interaction on spatial learning, in the same experimental conditions used for electrophysiology (TAT-2A40 versus TAT-SCR, 3 nmol/g, i.p., single injection). In the Spatial Object Recognition test, locating the object to a novel configuration during the T2 phase induced a significant treatment effect in terms of mean discrimination index between TAT-SCR- and TAT-2A40-treated mice (t18 = 5.61, \*\*\*p \< 0.0001, [Figure 5](#fig5){ref-type="fig"}D). During T1 phase, all groups of mice showed a similar mean exploration time for each object (TAT-SCR: Object 1 = 11.7 ± 1.0; Object 2 = 12.4 ± 0.96. TAT-2A40: Object 1 = 12.9 ± 0.82; Object 2 = 13.7 ± 0.75). During T2 phase two-way ANOVA revealed differences among groups (treatment effect: F(1,36) = 4.269, p \< 0.05; object effect: F(1,36) = 8.79, p = 0.0053; interaction treatment x object: F(1,36) = 12.28, p = 0.001). Post hoc analysis revealed that the mean exploration time of the displaced object was significantly higher than that of the stationary object after treatment with TAT-SCR ([Figure 5](#fig5){ref-type="fig"}E; ^\$\$\$^p \< 0.001 versus the corresponding stationary object). Conversely, no difference was shown in the mean exploration time between the two objects after treatment with TAT-2A40 ([Figure 5](#fig5){ref-type="fig"}E). The mean number of horizontal and vertical movements did not change between the two groups (Horizontal counts: t18 = 1.252, p = 0.23, [Figure 5](#fig5){ref-type="fig"}F; Vertical counts: t18 = 0.325, p = 0.74, [Figure 5](#fig5){ref-type="fig"}G).

Discussion {#sec3}
==========

The mechanism by which GluN2A-containing NMDARs accumulate at the synapse following activity-dependent plasticity and how this relates to the expression of given cognitive functions has been approached. Here we indicate that the formation of the Rph3A/GluN2A complex is needed for molecular and structural modifications of dendritic spines induced by LTP. *In vivo* disruption of Rph3A/GluN2A interaction by an interfering peptide leads to both LTP and spatial memory impairment corroborating this finding.

Rph3A is a Rab effector protein involved in neurotransmitter release at the presynaptic terminal, and its conformation and activity are strictly modulated by the presence of Ca^2+^ ions and IP3 ([@bib12], [@bib46], [@bib24]). Recently, Rph3A has been detected also at dendritic spines, where it interacts with and promotes synaptic retention of GluN2A-containing NMDARs ([@bib63]). Here we explored the molecular mechanisms by which Rph3A binds the GluN2A subunits following different paradigms of activity-dependent plasticity induced both *in vitro*, as cLTP or mGluR5 activation, and *in vivo* through enriched environment. All these forms of plasticity converge on promoting Rph3A accumulation at dendritic spines and its Ca^2+^/IP3-dependent interaction with the NMDAR subunit.

Our electron microscopy data eventually clarify the pre- and postsynaptic enrichment of Rph3A. We show by pre-embedding immunohistochemistry that about half of presynaptic terminals as well as dendritic spines in hippocampus display Rph3A, thus suggesting a similar distribution of the protein at the two sides of the excitatory synapse. Importantly, we observed that spines in which we detect Rph3A have an increased spine head area and PSD length and thickness, suggesting a higher stability of neuronal transmission through these Rph3A-positive connections.

Accumulation of GluN2A-containing NMDARs at synapse is a highly validated molecular event occurring after LTP induction ([@bib3], [@bib23], [@bib4]). Overall, these studies indicate that the GluN2A-containing NMDARs move at the synapses thanks to mobilization of preassembled NMDARs from non-synaptic pools. However, the molecular mechanisms responsible for a selective accumulation of receptors containing the GluN2A subunit are far to be understood. We show that Rph3A represents a needed protein in these processes thanks to its selective binding to GluN2A but not to other GluN2-type regulatory NMDAR subunits ([@bib63]). Different experimental protocols can be used to induce cLTP in dissociated hippocampal neurons, the treatment with glycine being the more commonly used ([@bib36]). Here we show that induction of cLTP by using the Forskolin/Rolipram/Picrotoxin cocktail in primary cultures acts by augmenting AMPAR surface insertion and phosphorylation at GluA1-Ser845 ([@bib28]) as well as NMDAR activity/synaptic stabilization. Notably, Rph3A interaction with GluN2A plays a key role in the increase of NMDAR activity at synapses. In addition, our results show now that induction of LTP promotes accumulation of Rph3A in mushroom-type dendritic spines, where it interacts with GluN2A-containing NMDARs thus leading to synaptic retention of the receptor ([@bib63]). This event is not associated with *de novo* Rph3A protein synthesis as indicated by cLTP experiments performed in the presence of anisomycin or by the puromycin-PLA assay. Moreover, activation of the mGluR/PLC pathway plays a fundamental role in these events also confirming that Ca^2+^/IP3 strictly modulate the capability of Rph3A to interact with protein partners ([@bib12], [@bib24]).

A number of previous studies demonstrated an involvement of mGluRs/PLC pathway in both LTP and LTD. Even if the role of mGluR-dependent synaptic LTD in physiology and disease is well established (see for review [@bib37]), activation of group I mGluRs through DHPG can facilitate also LTP through a PLC signaling cascade ([@bib11], [@bib67], [@bib44]). Interestingly, inhibition of phospholipase C by U73122 abolished the priming of LTP induced by DHPG ([@bib11]). Moreover, the LTP induction protocol can increase the amount of GluN2A at CA1 synapses in a mGluR5 and NMDAR-dependent manner ([@bib43]). In particular, in hippocampal CA1 pyramidal neurons, the developmental GluN2A/GluN2B switch driven acutely by activity requires activation of NMDARs and mGluR5 and it involves PLC activation ([@bib43]). Here, we demonstrate that *in vitro* activation of PLC is essential for cLTP-associated biochemical and morphological plasticity, driving Rph3A/GluN2A summon in PSD. Furthermore, activation of different PLC-grouped metabotropic receptors increased Rph3A protein levels at synapses, indicating PLC as a key enzyme upstream of Rph3A/GluN2A complex formation.

Furthermore, Rph3A silencing or disruption of Rph3A/NMDAR complex by an interfering peptide not only blocks GluN2A accumulation at postsynaptic membranes but also prevents the induction of LTP and formation of new spines. Notably, treatment of animals with either Rph3A silencing or cell permeable peptide disrupting Rph3A/NMDAR complex impairs the acquisition of spatial memories.

Our data are in close agreement with previous reports showing that rising of hippocampal GluN1/GluN2A NMDARs at synapses appears to be a general feature after novel spatial memory acquisition ([@bib8]). As reviewed by [@bib2], the GluN1/GluN2A subunits increase at synapse starting from about 20 to 30 min after plasticity induction or memory acquisition could represent a check point or a synaptic tag for plasticity establishment or memory consolidation ([@bib2]). Overall, our results demonstrate that GluN2A interaction with Rph3A is needed for NMDAR stabilization in hippocampal PSD after LTP induction and to trigger downstream signaling necessary for LTP synaptic adaptation and cognitive behavior.

Limitations of the Study {#sec3.1}
------------------------

Even if our results strengthen the putative role of Rph3A as an attractive pharmacological target for several neurological conditions in which GluN2A-containing NMDARs are not correctly functioning ([@bib58], [@bib33], [@bib61], [@bib20], [@bib45]), additional long-term studies in disease models are needed to confirm the involvement of Rph3A and Rph3A/GluN2A complex in these brain disorders.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods and Figures S1--S5

This work was supported by a PRIN 2015 grant of the Ministero dell'Istruzione, dell'Universita\` e della Ricerca to F.G. (2015FNWP34) and by a Ricerca Finalizzata Grant 2013 of the Ministero della Salute to F.G..

Author Contributions {#sec6}
====================

Investigation, L.F., J.S., E.Z., M.M., N.C., C.R., S.M., C.B., L.P., M.S., and G.O.; Formal analysis, L.F., J.S., E.Z., M.M., N.C., C.R., S.M., C.B., L.P., and M.S.; Methodology, A.P., M.S., and L.F.; Conceptualization, F.G., M.D.L., and E.M.; Writing -- Original Draft, L.C., J.S., and F.G.; Writing -- Review & Editing F.G., E.M., M.D.L., C.M., N.C., and C.R.; Supervision, F.G. and M.D.L.; Project administration and Funding Acquisition, F.G.

Declaration of Interests {#sec7}
========================

The authors declare that they have no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.isci.2019.08.036>.

[^1]: These authors contributed equally

[^2]: Senior author

[^3]: Present address: INSERM, Neurocentre Magendie, Planar Polarity and Plasticity, U1215 Bordeaux, France

[^4]: Lead Contact
